Multi-Center Study Concludes Nephros Mid-Dilution Hemodiafiltration Therapy Achieves Higher Clearance Of Low Molecular Weight Proteins

... Nephros, Inc. (Amex: NEP), announced today that the results of a randomized, multi-site scientific study indicate that the Company's Mid-Dilution Hemodiafiltration (Mid-HDF) therapy, using its OLpur MD 190 filter, offers the advantages of both pre- and post- HDF, and is "the most efficient dialysis procedure for Low-Molecular Weight Protein removal. [click link for full article] ...